{"id":119133,"date":"2017-12-29T06:30:41","date_gmt":"2017-12-28T22:30:41","guid":{"rendered":"\/\/m.iemloyee.com\/?p=119133"},"modified":"2017-12-26T19:02:58","modified_gmt":"2017-12-26T11:02:58","slug":"nature%e5%ad%90%e5%88%8a%ef%bc%9a%e5%85%b7%e6%9c%89%e6%9d%80%e7%97%85%e6%af%92%e6%8a%91%e5%88%b6%e6%9c%ba%e5%88%b6%e7%9a%84%e5%b9%bf%e8%b0%b1%e6%97%a0%e6%af%92%e6%8a%97%e7%97%85%e6%af%92%e7%ba%b3","status":"publish","type":"post","link":"\/\/m.iemloyee.com\/?p=119133","title":{"rendered":"Nature\u5b50\u520a\uff1a\u5177\u6709\u6740\u75c5\u6bd2\u6291\u5236\u673a\u5236\u7684\u5e7f\u8c31\u65e0\u6bd2\u6297\u75c5\u6bd2\u7eb3\u7c73\u9897\u7c92"},"content":{"rendered":"
\u3010\u5f15\u8a00\u3011<\/strong><\/p>\n \u4f20\u67d3\u6027\u75be\u75c5\u5360\u5168\u7403\u6b7b\u4ea1\u7387\u768420\uff05\uff0c\u800c\u75c5\u6bd2\u53c8\u5360\u8fd9\u4e9b\u6b7b\u4ea1\u4eba\u6570\u7684\u4e09\u5206\u4e4b\u4e00\u3002\u4e0b\u547c\u5438\u9053\u611f\u67d3\u548c\u4eba\u7c7b\u514d\u75ab\u7f3a\u9677\u75c5\u6bd2\uff08HIV\uff09\u662f\u4e16\u754c\u8303\u56f4\u5185\u5341\u79cd\u6700\u5e38\u89c1\u7684\u6b7b\u4ea1\u539f\u56e0\u4e4b\u4e00\uff0c\u65b0\u51fa\u73b0\u7684\u75c5\u6bd2\uff08\u4f8b\u5982\u57c3\u535a\u62c9\u75c5\u6bd2\uff09\u7684\u6b7b\u4ea1\u4eba\u6570\u6b63\u5728\u9010\u5e74\u589e\u52a0\u3002\u53ef\u7528\u7684\u6297\u75c5\u6bd2\u836f\u7269\u662f\u9488\u5bf9\u6709\u9650\u7684\u4eba\u7c7b\u75c5\u539f\u4f53\u7684\u75c5\u6bd2\u7279\u5f02\u6027\u548c\u6d3b\u6027\u7684\u3002\u5e7f\u8c31\u7269\u8d28\u53ef\u4ee5\u901a\u8fc7\u6a21\u62df\u786b\u9178\u4e59\u9170\u809d\u7d20\u86cb\u767d\u591a\u7cd6\uff08HSPG\uff09\u8fd9\u4e00\u75c5\u6bd2\u8fde\u63a5\u914d\u4f53\uff08VALs\uff09\u9776\u4f4d\u6765\u963b\u6b62\u75c5\u6bd2\u4e0e\u7ec6\u80de\u76f8\u4e92\u4f5c\u7528\u3002\u53ef\u9006\u7684\u7ed3\u5408\u673a\u5236\u963b\u6b62\u4e86\u5b83\u4eec\u4f5c\u4e3a\u836f\u7269\u7684\u4f7f\u7528\uff0c\u56e0\u4e3a\u7a00\u91ca\u540e\uff0c\u6291\u5236\u4f5c\u7528\u4e27\u5931\u4e86\u3002\u5df2\u77e5\u7684VALs\u7531\u7d27\u5bc6\u5305\u88c5\u7684\u91cd\u590d\u5355\u5143\u5236\u6210\uff0c\u4f46\u662f\u4e0a\u8ff0\u7269\u8d28\u4ec5\u80fd\u7ed3\u5408\u5176\u4e2d\u7684\u51e0\u79cd\u3002<\/p>\n \u3010\u6210\u679c\u7b80\u4ecb\u3011<\/strong><\/p>\n \u8fd1\u65e5\uff0c\u6d1b\u6851\u8054\u90a6\u7406\u5de5\u5b66\u9662Francesco Stellacci\uff08\u901a\u8baf\u4f5c\u8005\uff09<\/strong>\u56e2\u961f\u8bbe\u8ba1\u4e86\u6a21\u4effHSPG\u7684\u6297\u75c5\u6bd2\u7eb3\u7c73\u9897\u7c92\uff0c\u75c5\u6bd2\u4e0eVAL\u91cd\u590d\u5355\u5143\u7684\u7ed3\u5408\u6700\u7ec8\u4ea7\u751f\u4f7f\u75c5\u6bd2\u4e0d\u53ef\u9006\u53d8\u5f62\u7684\u529b\uff08\u301c190pN\uff09\u3002\u75c5\u6bd2\u68c0\u6d4b\uff0c\u7535\u5b50\u663e\u5fae\u955c\u56fe\u50cf\u548c\u5206\u5b50\u52a8\u529b\u5b66\u6a21\u62df\u90fd\u8bc1\u660e\u4e86\u6240\u63d0\u51fa\u7684\u673a\u5236\u3002\u8fd9\u4e9b\u9897\u7c92\u4e0d\u5177\u6709\u7ec6\u80de\u6bd2\u6027\uff0c\u5e76\u4e14\u4f53\u5916\u7eb3\u6469\u5c14\u4e0d\u53ef\u9006\u6d3b\u6027\u53ef\u4ee5\u5bf9\u6297\u5355\u7eaf\u75b1\u75b9\u75c5\u6bd2\uff08HSV\uff09\uff0c\u4eba\u4e73\u5934\u7624\u75c5\u6bd2\uff0c\u547c\u5438\u9053\u5408\u80de\u75c5\u6bd2\uff08RSV\uff09\uff0c\u767b\u9769\u70ed\u548c\u6162\u75c5\u6bd2\u3002\u76f8\u5173\u6210\u679c\u4ee5\u9898\u4e3a\u201cBroad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism<\/strong>\u201d\u53d1\u8868\u5728\u4e86Nature Materials<\/strong>\u4e0a\u3002<\/p>\n \u3010\u56fe\u6587\u5bfc\u8bfb\u3011<\/strong><\/p>\n \u56fe1 MUS\uff1aOT-NPs\u7684\u6297\u75c5\u6bd2\u6d3b\u6027<\/strong><\/p>\n a\uff09MUS\uff1aOT-NPs\u4e0eMES-NPs\u76f8\u6bd4\u7684\u6297\u75c5\u6bd2\u6d3b\u6027<\/p>\n b\uff09\u809d\u7d20\uff0cMES-NP\u548cMUS\uff1aOT-NPs\u75c5\u6bd2\u611f\u67d3\u6027\u66f2\u7ebf\u548c\u6297\u75c5\u6bd2\u6d4b\u5b9a<\/p>\n c\uff09\u9488\u5bf9HPV-16\uff0cRSV\uff0cLV-VSV-G\uff08\u663e\u793a\u4e3aLV\uff09\u548cDENV-2\u75c5\u6bd2\u7684MUS\u5305\u8986\u7684NPs\u7684\u6297\u75c5\u6bd2\u6d3b\u6027<\/p>\n d\uff09MUS\uff1aOT-NPs\u5bf9HSV-2\u7684\u75c5\u6bd2\u611f\u67d3\u6027\u5bf9\u65f6\u95f4\uff08\u5206\u949f\uff09\u7684\u6291\u5236<\/p>\n \u56fe2 HSV-2\u53ca\u5176\u4e0eMUS\uff1aOT-NPs\u7684\u5173\u8054<\/strong><\/p>\n a-c\uff09\u4f7f\u7528\u5e72\u71e5\u9634\u6027\u67d3\u8272\u7684TEM\uff08a\uff09\u6216\u672a\u67d3\u8272\u7684\u4f4e\u6e29-TEM\uff08b\uff0cc\uff09<\/p>\n d\uff09\u4e0eHSV-2\u6709\u5173\u7684NPs\uff08MES\u6216MUS\uff1aOT\uff09\u7684\u767e\u5206\u6bd4\u548c\u5206\u5e03<\/p>\n \u56fe3 \u5206\u5b50\u52a8\u529b\u5b66\u6a21\u62df<\/strong><\/p>\n a\uff09\u78fa\u5316MUS\u7684\u9876\u89c6\u56fe\uff1aOT-NP\uff082.4nm\u6838\u5fc3\uff09<\/p>\n b\uff09\u793a\u610f\u56fe\u8bf4\u660e\u4e86MUS\u578bNPs\u4e0eHSPG\u7ed3\u5408\u6b8b\u57fa\u7684\u5f3a\u591a\u4f4d\u70b9\u7ed3\u5408\u80fd\u591f\u5f15\u8d77\u4e0d\u53ef\u9006\u7684\u6539\u53d8<\/p>\n \u3010\u5c0f\u7ed3\u3011<\/strong><\/p>\n \u76f8\u4fe1\u8be5\u7814\u7a76\u4ecb\u7ecd\u7684\u65b9\u6cd5\u6709\u673a\u4f1a\u884d\u751f\u533b\u5b66\u76f8\u5173\u7684\u6297\u75c5\u6bd2\u836f\u7269\u6765\u5bf9\u6297\u75c5\u6bd2\u611f\u67d3\u3002\u8be5\u5de5\u4f5c\u53d1\u73b0\u7684\u7ed3\u679c\u663e\u793a\u51fa\u4f18\u4e8eHSV-2\u548cLS-VSV-G\u7684\u6740\u75c5\u6bd2\u6d3b\u6027\uff0c\u800c\u5bf9HPV\u548cRSV\u7684\u6d3b\u6027\u867d\u7136\u663e\u8457\uff0c\u4f46\u8fd8\u5e94\u8be5\u7ee7\u7eed\u6539\u5584\u3002\u603b\u4f53\u800c\u8a00\uff0c\u8fd9\u91cc\u63d0\u51fa\u7684\u7b56\u7565\u662f\u5728\u5168\u7403\u8bb8\u591a\u75c5\u6bd2\u611f\u67d3\u7684\u6cbb\u7597\u65b9\u9762\u8fc8\u51fa\u7684\u7b2c\u4e00\u6b65\u3002\u786e\u5b9a\u8fd9\u4e00\u53d1\u73b0\u7684\u9884\u9632\u6216\u6cbb\u7597\u7528\u9014\u662f\u5426\u5408\u9002\u9700\u8981\u8fdb\u4e00\u6b65\u6df1\u5165\u7684\u4f53\u5185\u5b9e\u9a8c\u3002<\/p>\n \u6587\u732e\u94fe\u63a5\uff1a<\/strong>Broad-spectrum non-toxic antiviral nanoparticles with a virucidal inhibition mechanism<\/a>\uff08Nat. Mater., 2017, DOI:10.1038\/nmat5053\uff09<\/p>\n \u6587\u7531\u6750\u6599\u4eba\u751f\u7269\u6750\u6599\u7ec4Allen\u4f9b\u7a3f\uff0c\u6750\u6599\u725b\u6574\u7406\u7f16\u8f91\u3002<\/p>\n \u6750\u6599\u725b\u7f51\u4e13\u6ce8\u4e8e\u8ddf\u8e2a\u6750\u6599\u9886\u57df\u79d1\u6280\u53ca\u884c\u4e1a\u8fdb\u5c55\uff0c\u8fd9\u91cc\u6c47\u96c6\u4e86\u5404\u5927\u9ad8\u6821\u7855\u535a\u751f\u3001\u4e00\u7ebf\u79d1\u7814\u4eba\u5458\u4ee5\u53ca\u884c\u4e1a\u4ece\u4e1a\u8005\uff0c\u5982\u679c\u60a8\u5bf9\u4e8e\u8ddf\u8e2a\u6750\u6599\u9886\u57df\u79d1\u6280\u8fdb\u5c55\uff0c\u89e3\u8bfb\u9ad8\u6c34\u5e73\u6587\u7ae0\u6216\u662f\u8bc4\u8ff0\u884c\u4e1a\u6709\u5174\u8da3\uff0c\u70b9\u6211\u52a0\u5165\u7f16\u8f91\u90e8\u5927\u5bb6\u5ead<\/a>\u3002<\/p>\n \u6b22\u8fce\u5927\u5bb6\u5230\u6750\u6599\u4eba\u5ba3\u4f20\u79d1\u6280\u6210\u679c\u5e76\u5bf9\u6587\u732e\u8fdb\u884c\u6df1\u5165\u89e3\u8bfb\uff0c\u6295\u7a3f\u90ae\u7bb1tougao@cailiaoren.com\u3002<\/p>\n \u6295\u7a3f\u4ee5\u53ca\u5185\u5bb9\u5408\u4f5c\u53ef\u52a0\u7f16\u8f91\u5fae\u4fe1\uff1aRDD-2011-CHERISH\uff0c\u4efb\u4e39\u4e39\uff0c\u6211\u4eec\u4f1a\u9080\u8bf7\u5404\u4f4d\u8001\u5e08\u52a0\u5165\u4e13\u5bb6\u7fa4\u3002
<\/p>\n
<\/p>\n
<\/p>\n
\n <\/b><\/strong><\/p>\n